Business Description
AcuCort AB
ISIN : SE0009695927
Description
AcuCort AB is an innovative biotechnology company that identifies, develops and commercializes smart drugs that meet the patient's needs for a user-friendly and effective treatment.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | No Debt | |||||
| Equity-to-Asset | 0.95 | |||||
| Piotroski F-Score | 2/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 19.6 | |||||
| 3-Year EPS without NRI Growth Rate | -13.7 | |||||
| 3-Year FCF Growth Rate | 17.4 | |||||
| 3-Year Book Growth Rate | -31.7 |
Momentum Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 25.22 | |||||
| 9-Day RSI | 31.84 | |||||
| 14-Day RSI | 34.85 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 4.63 | |||||
| Quick Ratio | 4.63 | |||||
| Cash Ratio | 4.1 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -47.8 | |||||
| Shareholder Yield % | -10.88 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -34.35 | |||||
| ROA % | -30.41 | |||||
| ROIC % | -34.88 | |||||
| ROCE % | -32.53 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 1.96 | |||||
| Price-to-Tangible-Book | 4.82 | |||||
| EV-to-EBIT | -5.25 | |||||
| EV-to-EBITDA | -5.25 | |||||
| EV-to-FCF | -3.48 | |||||
| Price-to-Net-Current-Asset-Value | 4.82 | |||||
| Earnings Yield (Greenblatt) % | -19.05 | |||||
| FCF Yield % | -29.65 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
AcuCort AB Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | |||
| EPS (TTM) (€) | -0.02 | ||
| Beta | 0 | ||
| Volatility % | 0 | ||
| 14-Day RSI | 34.85 | ||
| 14-Day ATR (€) | 0.005559 | ||
| 20-Day SMA (€) | 0.05934 | ||
| 12-1 Month Momentum % | 0 | ||
| 52-Week Range (€) | 0.0456 - 0.0914 | ||
| Shares Outstanding (Mil) | 119.17 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
AcuCort AB Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
AcuCort AB Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
AcuCort AB Frequently Asked Questions
What is AcuCort AB(STU:NV5)'s stock price today?
The current price of STU:NV5 is €0.05. The 52 week high of STU:NV5 is €0.09 and 52 week low is €0.05.
When is next earnings date of AcuCort AB(STU:NV5)?
The next earnings date of AcuCort AB(STU:NV5) is 2025-02-14 Est..
Does AcuCort AB(STU:NV5) pay dividends? If so, how much?
AcuCort AB(STU:NV5) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers